Current targeted panel testing for people with schwannomas normally includes sequencing of NF2, SMARCB1 and LZTR1. In some institutions, screening also includes the genes DGCR8 and SMARCA4, although associations with schwannomatosis are extremely rare [84, 85]. Here, NF2 is linked to schwannomatosis.